Calls
2
Mike Doukeris
CEO, Anheuser-Busch InBev
Win Rate
0.0%
return
-48.6%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jun 09
$80.90
-0.4%
AB InBev manages cost inflation through pricing with inflation, foreign exchange diversification, and productivity, maintaining stable price increases historically and avoiding volatile price moves, even amid higher aluminum costs from tariffs.
Packaged Foods
Short
Feb 11
$16.69
-96.8%
Novo Nordisk has filed lawsuits against Hims & Hers (and others) for patent infringement regarding compounded GLP-1s. If NVO successfully blocks the sale of compounded semaglutide, HIMS loses a massive, high-margin revenue stream that has driven its recent growth. SHORT. Regulatory and legal headwinds are mounting against the "mass compounding" business model. Lawsuits could drag on for years; FDA could maintain shortage list status allowing compounding to continue.
Novo Nordisk has filed lawsuits against Hims & Hers (and others) for patent infringement regarding compounded GLP-1s. If NVO successfully blocks the sale of compounded semaglutide, HIMS loses a massive, high-margin revenue stream that has driven its recent growth. SHORT. Regulatory and legal headwinds are mounting against the "mass compounding" business model. Lawsuits could drag on for years; FDA could maintain shortage list status allowing compounding to continue.
GLP-1 / Obesity
Showing 2 of 2 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Mike Doukeris has 2 trade ideas tracked on Buzzberg across 2 tickers since February 2026. Most covered: HIMS, BUD.
